A comparative proteomic analysis of the rat brain during rebound hyperphagia induced by space-restriction

Molecular and Cellular Biochemistry

Volumn 276, Issue 1-2, 2005, Pages 21-29

  Ishihara, Keiichi ^a   Nakata, Kyoko ^a   Yamagishi, Nobuyuki ^a   Iwasaki, Shinichi ^b   Kiriike, Nobuo ^b   Hatayama, Takumi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Binge eating; Hippocampus; Proteomics; Rat; Rebound hyperphagia; Thalamus hypothalamus

Indexed keywords

BRAIN PROTEIN; PHOSPHATIDYLETHANOLAMINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINGE EATING DISORDER; BRAIN LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DIET RESTRICTION; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HYPOTHALAMUS; MASS SPECTROMETRY; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; REBOUND; SEQUENCE ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CROWDING; FEEDING BEHAVIOR; FEMALE; HYPERPHAGIA; PROTEOMICS; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL;

ANIMALIA;

EID: 24144461745     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-2465-x     Document Type: Article

References (23)

1. American Psychiatric Association 1994 Diagnostic and Statistical Manual of Mental Disorders. 4th edn. American Psychiatric Press Washington DC
2. Runderman AJ: Dietary restraint: A theoretical and empirical review. Psychol Bull 99: 249-262, 1986
3. CP Herman J Polivy 1988 Studies of eating in normal dieters. In B.T. Walsh (ed). Eating Behavior in Eating Disorders. American Psychiatric Press, Washington DC pp. 95-111
4. Wardle J: Compulsive eating and dietary restraint. Br J Clin Psychol 26: 47-55, 1987 3828596
5. Tushl RJ: From dietary restraint to binge eating: Some theoretical considerations. Appetite 14: 105-109, 1990 10.1016/0195-6663(90)90004-R
6. Goodwin GM, Fairburn CG, Cowen PJ: The effects of dieting and weight loss on neuroendocrine response to tryptophan, clonidine, and apomorphine in volunteers. Arch Gen Psychiatry 44: 952-957, 1987 3675135
7. Kaye WH, Weltzin TE: Serotonin activity in anorexia and bulimia nervosa: Relationship to the modulation of feeding and mood. J Clin Psychiatry 52: 41-48, 1991
8. Jimerson DC, Lesem MD, Kaye WH, Brewerton TD: Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49: 132-138, 1992 1372494
9. Inoue K, Kiriike N, Okuno M, Fujisaki Y, Kurioka M, Iwasaki S, Yamagami S: Prefrontal and striatal dopamine metabolism during enhanced rebound hyperphagia induced by space restriction - A rat model of binge eating. Biol Psychiatry 44: 1329-1336, 1998 10.1016/S0006-3223(97)00518-0
10. Lowry OH, Rowebrough NJ, Farr AL, Randa RJ: Protein measurement with the folin phenol regent. J Biol Chem 193: 265-275, 1951 14907713
11. Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J: The neuron-specific protein PGP 9.5 is an ubiquitin carboxyl-terminal hydrolase. Science 246: 670-673, 1989 2530630
12. Larsen CN, Krantz BA, Wilkinson KD: Substrate specificity of deubiquitinating enzymes: Ubiquitin C-terminal hydrolase. Biochemistry 37: 3358-3368, 1998 10.1021/bi972274d
13. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH: The ubiquitin pathway in Parkinson's disease. Nature 395: 451-452, 1998 10.1038/26652
14. Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, Kiyosawa H, Harada T, Ichihara N, Wakana S, Kikuchi T, Wada K: Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet 23: 47-51, 1999 10471497
15. Nicholls DG, Budd SL: Mitochondoria and neuronal glutamate excitotoxicity. Biochem Biophys Acta 1366: 97-112, 1998 9714760
16. Floyd RA: Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222: 236-245, 1999 10.1046/ j.1525-1373.1999.d01-140.x
17. Wood ZA, Poole LB, Karplus PA: Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300: 650-653, 2003 10.1126/science.1080405
18. Chae HZ, Chung SJ, Rhee SG: Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 269: 27670-27678, 1994 7961686
19. Chae HZ, Kim HJ, Kang SW, Rhee SG: Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract 45: 101-102, 1999 10.1016/ S0168-8227(99)00037-6
20. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG: Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J Biol Chem 273: 6297-6302, 1998 10.1074/jbc.273.11.6297
21. Bernier I, Jolles P: Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain. Biochim Biophys Acta 790: 174-181, 1984 6435678
22. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W: Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401: 173-177, 1999 10.1038/43686
23. Hengst U, Albrecht H, Hess D, Monard D: The phophati- dylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors. J Biol Chem 276: 535-540, 2001 10.1074/ jbc.M002524200